Stepwise treatment strategies and prognostic determinants in emphysematous pyelonephritis: A retrospective 10-year high-volume centre experience
Journal of Clinical Urology · 2026-11 · 19 (6) · 580-589
DOI: 10.1177/20514158261422389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Urology, online erschienen am 17.03.2026. Verfasst von Manuel Guillermo Ruelas-Martinez und 7 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
To identify clinical, microbiological, and radiological factors associated with mortality in patients with emphysematous pyelonephritis (EPN) and to assess renal outcomes according to treatment strategy at a high-volume centre in Northern Mexico.
Methods
We conducted an ambispective cross-sectional study including 125 patients diagnosed with EPN between 2014 and 2024. Clinical, laboratory, and imaging data were collected. Disease severity was classified using the Huang-Tseng system. Patients were managed with medical therapy alone, minimally invasive intervention (MMI), or nephrectomy. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of mortality.
Results
The mean age was 50.2 years, and 78.4% were women. Diabetes mellitus was present in 84.8% of cases. Escherichia coli was the most frequent pathogen (67.1%), and 34.2% of isolates were ESBL-producing. Overall mortality was 9.6%. On multivariate analysis, advanced age (OR = 1.08; 95% CI = 1.02–1.15; p = 0.008) and Huang-Tseng ⩾ 3b (OR = 5.68; 95% CI = 1.41–22.96; p = 0.015) were independent predictors of mortality. eGFR significantly improved after MMI (37.1→54.7 mL/min/1.73 m 2 ; p < 0.001) and nephrectomy (21.5→59.2 mL/min/1.73 m 2 ; p = 0.009), but not with medical therapy alone ( p = 0.82).
Conclusions
Advanced radiological severity and older age were the strongest predictors of mortality in EPN. Minimally invasive management and timely nephrectomy improved renal function among survivors, highlighting the importance of early, individualised, and stepwise treatment guided by radiological staging and clinical stability. Level of evidence: III
Zitieren
APA
Ruelas-Martinez, M. G., Ictech, A. E. C., Badin-Castro, J., Martínez, A. Z., Benitez, A. C., Ruiz, L. E. S., Ayala, R. G., & Barrera-Juárez, E. (2026). Stepwise treatment strategies and prognostic determinants in emphysematous pyelonephritis: A retrospective 10-year high-volume centre experience. Journal of Clinical Urology, 19(6), 580-589. https://doi.org/10.1177/20514158261422389
Vancouver
Ruelas-Martinez MG, Ictech AEC, Badin-Castro J, Martínez AZ, Benitez AC, Ruiz LES, et al. Stepwise treatment strategies and prognostic determinants in emphysematous pyelonephritis: A retrospective 10-year high-volume centre experience. Journal of Clinical Urology. 2026;19(6):580-589. doi:10.1177/20514158261422389
BibTeX
@article{RuelasMartinez2026,
author = {Ruelas-Martinez, Manuel Guillermo and Ictech, Aristides Epaminondas Craniotis and Badin-Castro, Jonathan and Martínez, Adriana Zamudio and Benitez, Alexis Covarrubias and Ruiz, Luis Eduardo Salinas and Ayala, Rodrigo González and Barrera-Juárez, Eduardo},
title = {Stepwise treatment strategies and prognostic determinants in emphysematous pyelonephritis: A retrospective 10-year high-volume centre experience},
journal = {Journal of Clinical Urology},
year = {2026},
volume = {19},
number = {6},
pages = {580--589},
doi = {10.1177/20514158261422389}
}
EUVIMED